Eberlein, T J <br/><br/>
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  1989 
 - 145-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF01669422  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Cytotoxicity, Immunologic<br/>Humans<br/>Interleukin-2--pharmacokinetics<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Lymphocytes--immunology<br/>Neoplasms--therapy<br/>Phenotype<br/>Recombinant Proteins--pharmacokinetics